HW
JAZZ icon

Hancock Whitney’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hancock Whitney’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
6,649
+2,228
+50% +$488K 0.03% 361
2026
Q1 		$898K Buy
4,421
+72
+2% +$12.6K 0.02% 450
2025
Q4 		$739K Buy
4,349
+38
+0.9% +$5.83K 0.01% 474
2025
Q3 		$568K Buy
4,311
+57
+1% +$6.84K 0.01% 534
2025
Q2 		$451K Buy
4,254
+1,605
+61% +$174K 0.01% 584
2025
Q1 		$329K Buy
+2,649
New +$346K 0.01% 530
2022
Q3 		– Sell
-3,952
Closed -$617K – 631
2022
Q2 		$617K Sell
3,952
-1,941
-33% -$299K 0.02% 384
2022
Q1 		$918K Sell
5,893
-38,540
-87% -$5.59M 0.03% 338
2021
Q4 		$5.66M Sell
44,433
-1,050
-2% -$138K 0.18% 114
2021
Q3 		$5.92M Buy
45,483
+79
+0.2% +$11.9K 0.21% 100
2021
Q2 		$8.07M Sell
45,404
-26,302
-37% -$4.56M 0.26% 88
2021
Q1 		$11.8M Buy
71,706
+495
+0.7% +$81.5K 0.4% 61
2020
Q4 		$11.8M Sell
71,211
-994
-1% -$148K 0.39% 58
2020
Q3 		$10.3M Sell
72,205
-5,514
-7% -$684K 0.38% 66
2020
Q2 		$8.58M Buy
77,719
+14,434
+23% +$1.6M 0.33% 73
2020
Q1 		$6.31M Buy
63,285
+28,985
+85% +$3.75M 0.25% 109
2019
Q4 		$5.12M Buy
34,300
+696
+2% +$94.7K 0.17% 160
2019
Q3 		$4.31M Buy
33,604
+29,599
+739% +$3.97M 0.14% 193
2019
Q2 		$571K Buy
4,005
+17
+0.4% +$2.29K 0.02% 590
2019
Q1 		$570K Buy
3,988
+226
+6% +$29.5K 0.02% 590
2018
Q4 		$466K Buy
3,762
+77
+2% +$11.4K 0.02% 610
2018
Q3 		$620K Buy
+3,685
New +$634K 0.02% 599

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Hancock Whitney's JAZZ Position: Q2 2026 in Review

Hancock Whitney increased its Jazz Pharmaceuticals (JAZZ) stake by 50% in Q2 2026, buying an estimated $488K and bringing the position to 6,649 shares worth $1.6M. The position accounts for 0.03% of the portfolio, ranked #361.

Hancock Whitney first reported a position in JAZZ in Q3 2018 and has held it in 22 quarters since. The position peaked at $11.8M in Q1 2021. 645 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Hancock Whitney held 6,649 shares of Jazz Pharmaceuticals worth $1.6M as of Q2 2026.
  • Hancock Whitney bought 2,228 Jazz Pharmaceuticals shares in Q2 2026, an estimated $488K.
  • Jazz Pharmaceuticals made up 0.03% of Hancock Whitney's portfolio in Q2 2026, its #361 holding.
  • Hancock Whitney first reported a position in Jazz Pharmaceuticals in Q3 2018 and has held it in 22 quarters since.
  • Hancock Whitney's Jazz Pharmaceuticals position peaked at $11.8M in Q1 2021.
  • 645 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.